Which statement best describes the scientific rationale for administering a mydriatic ophthalmic medication to a client diagnosed with glaucoma?
1. It constricts the pupil, which causes the pupil to dilate in low light.
2. It dilates the pupil to reduce the production of aqueous humor.
3. It decreases production of aqueous humor but does not affect the eye.
4. It is used as adjunctive therapy primarily to reduce intraocular pressure.
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here